	Mechanisms of breast cancer dormancy in bone metastasis. Clin Exp Metastasis Price ML, Zhou J, Le Maitre CL, Quayle LA, Ottewell PD. PMID: 42234001 [PubMed - in process]
	Impact of nanocarrier mediated drug delivery systems: a deep dive into therapeutics and clinical management of breast cancer. Nanomedicine (Lond) Hanif S, Shahid N, Iqbal J, Yasir S, Arfat Idrees H, Farooq MI, Rai N, Ali Syed M, Noreen S. PMID: 42233624 [PubMed - as supplied by publisher]
	AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026. Breast Care (Basel) Park-Simon TW, Müller V, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, Blohmer JU, Dall P, Ditsch N, Fallenberg EM, Fasching PA, Fehm T, Friedrich M, Gluz O, Harbeck N, Hartkopf AD, Heil J, Hörner-Rieber J, Huober J, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Reimer T, Reinisch M, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Untch M, van Mackelenbergh MT, Witzel I, Wöckel A, Wuerstlein R, Janni W, Thill M. PMID: 42233150 [PubMed - as supplied by publisher]
	Quality of Life Assessment after Breast Cancer Treatment using EORTC QLQ-C30 and BR-23 Questionnaire: A Prospective Study. Indian J Palliat Care Kaur M, Dahiya D, Pantha B, Yadav BS, Kumar P. PMID: 42233137 [PubMed]
	Photothermal Therapy Using Ag/TiO2 Core-Shell Nanoparticles Against Breast Cancer Cell Line: an In Vitro and In Vivo Study. J Lasers Med Sci Mohammad MH, Khalaf OH, Al-Attar HM, Almzaien AK, Alwan AH, Ajeel AK, Hassoon HA, Hussein RAA, Ahmed AA. PMID: 42233113 [PubMed]
	Retraction: Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer. RSC Adv Alqahtani NF, Alfaifi MY, Shati A A, Elbehairi SEI, Saleh AM, Kotb ES, Serag WM, Elshaarawy RFM, Alhamdi HW, Hassan YA. PMID: 42232918 [PubMed]
	Artificial Intelligence-Driven Quantitative HER2 Scoring and Spatial Bystander Effect Modeling for ADC Response Stratification in HER2-Low Breast Cancer. Breast Cancer (Dove Med Press) Liu J, Zhang X. PMID: 42232721 [PubMed]
	Microbiome and Response to Therapy in Triple Negative Breast Cancer: A Systematic Review. Oncol Res Lopes M, Vila Nova C, Oliveira RC, Schmitt F, Mendes F, Martins D. PMID: 42232608 [PubMed - in process]
	Neoadjuvant FinHer regimen in patients with HER2-positive breast cancer: a retrospective audit. Front Oncol T M A, Joseph R, Mathew S, Mathew M, Soman S, Bharathi K, S S. PMID: 42232550 [PubMed]
	Probabilistic mapping of lymph node metastasis in epithelial ovarian cancer: a retrospective cohort study using Bayesian network analysis. Front Oncol Xu H, Wu C, Chen Y, Wu L, Ling Q, Yang S, Lai H, Wen W, Tan H, Yao S, Sun T, Yang G. PMID: 42232532 [PubMed]
	Multi-omics landscape and functional validation of HCCS in breast cancer: from pan-cancer immunometabolic characterization to regulating tumor proliferation. Front Genet Cheng H, Li C. PMID: 42232519 [PubMed]
	Effectiveness of Community-Based Breast Cancer Screening Using Full-Field Digital Mammography With Digital Breast Tomosynthesis in an Urban Population in Central India: An Observational Study. Cureus Pande S, Dakhore S, Arora D, Juvekar S. PMID: 42232009 [PubMed]
	Recurrent Myopericytoma of the Breast Mimicking Phyllodes Tumour: A Diagnostic and Management Challenge. Int J Surg Pathol Paliwal P, Jyoti S, Singh NA, Ahuja A. PMID: 42231815 [PubMed - as supplied by publisher]
	Ferroptosis and chemotherapy resistance in ovarian cancer: molecular mechanisms and therapeutic opportunities. J Ovarian Res Li S, Yang L, Zhu Z. PMID: 42231453 [PubMed - as supplied by publisher]
	Frailty and associated factors in women aged 65 years and older with breast cancer: a cross-sectional study. BMC Geriatr Wang S, Feng S, Shen A, Qiang W, Tang Q. PMID: 42231192 [PubMed - as supplied by publisher]
	Diagnostic performance of kinetic parameters of ultrafast breast MRI and their associations with immunohistopathological findings of breast carcinoma. Sci Rep Kobayashi A, Matsuda M, Okada K, Matsuda T, Ebihara R, Ochi H, Kawaguchi N, Shiraishi Y, Takimoto Y, Ihara Y, Kamei Y, Kurata M, Kitazawa R, Kido T. PMID: 42230942 [PubMed - as supplied by publisher]
	Diagnostic Performance of (68)Ga-FAPI PET/CT Versus (18)F-FDG PET/CT in Evaluating Neoadjuvant Therapy Pathological Response in Breast Cancer. NPJ Breast Cancer Zhu S, Jin Y, Hu C, Fan Y, Fei X, Hu J, Chen X. PMID: 42230653 [PubMed - as supplied by publisher]
	Predictive Features Specific to FIGO IIIA1 Ovarian Cancer: What Drives Prognosis. Ann Surg Oncol Bruno M, Arrigo D, Paratore M, Lopopolo G, Gallotta V, Rosati A, D'Indinosante M, Fagotti A. PMID: 42230470 [PubMed - as supplied by publisher]
	Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer. Ann Oncol Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Rubovszky G, Tondini C, Ciruelos EM, Gomez HL, Bonnefoi HR, Burstein HJ, Chini C, Puglisi F, Spazzapan S, Bernardo A, Climent MA, Bellet M, Ruhstaller T, Bermejo B, Chia SKL, Martino S, Geyer CE Jr, Goetz MP, Ingle JN, Stearns V, Davidson NE, Le Du F, Müller B, Coleman RE, Loibl S, Winer EP, Ruepp B, Loi S, Láng I, Coates AS, Gelber RD, Goldhirsch A, Regan MM, International Breast Cancer Study Group, SOFT and TEXT Investigators. PMID: 42229584 [PubMed - as supplied by publisher]
	Impact of adjuvant breast radiotherapy on the risk and the survival of second primary lung cancer: a large population-based study. Jpn J Clin Oncol Ji NN, Yang XY, Xiao SQ, Zhao N, Su WL, Xu JN, Shao L, Li SN, Zeng YC. PMID: 42228854 [PubMed - as supplied by publisher]

Articles 1 - 20 / 329605

Page 1 of 16481



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy